Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Moulin

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2013
Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndromeM Le Quintrec, J Zuber, B Moulin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER studyY Lebranchu, R Snanoudj, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' studyL Frimat, E Cassuto-Viguier, B Charpentier, et al.
BMC Infectious Diseases|August 4, 2016
Ruling out nosocomial transmission of Cryptosporidium in a renal transplantation unit: case reportJ Brunet, J P Lemoine, B Pesson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 27, 2015
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsAL Rostaing, A Hertig, L Albano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2007
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroidsM Büchler, S Caillard, S Barbier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept studyY Lebranchu, A Thierry, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimusA Servais, V Meas-Yedid, O Toupance, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2013
Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndromeM Le Quintrec, J Zuber, B Moulin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER studyY Lebranchu, R Snanoudj, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' studyL Frimat, E Cassuto-Viguier, B Charpentier, et al.
BMC Infectious Diseases|August 4, 2016
Ruling out nosocomial transmission of Cryptosporidium in a renal transplantation unit: case reportJ Brunet, J P Lemoine, B Pesson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 27, 2015
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsAL Rostaing, A Hertig, L Albano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 18, 2007
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroidsM Büchler, S Caillard, S Barbier, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 9, 2009
Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept studyY Lebranchu, A Thierry, O Toupance, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 19, 2016
Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeN Pallet, I Etienne, M Buchler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 22, 2009
Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimusA Servais, V Meas-Yedid, O Toupance, et al.
Pageof 13